Housing prices in the United Kingdom rose during the month of October, although revealing the second-weakest performance out of the nine areas surveyed and London remaining the country’s worst performing region.
Asking prices in the capital have risen 2.5 percent in the past year, data released by property website operator Rightmove showed Monday. On a yearly basis, house prices jumped 4.2 percent, up from 4.0 percent in the previous month.
On a monthly basis, asking prices in London rose 2.4 percent in October, while prices nationally increased 0.9 percent, compared to the 0.7 percent increase in September, the data showed.
Further, the number of sales agreed jumped 6.0 percent on-year. By region, total available stock in the south jumped an annual 16 percent, while stock in the north dropped 11.0 percent.
The average price of a house in the capital city of London is GBP645,833 or USD787,000, which is nearly double the national average, forcing home-buyers to search for options outside London to buy residential properties.
"London used to be the country’s jewel in the crown as far as an increase in property prices was concerned and it will come back again," Bloomberg reported, citing Miles Shipside, Analyst, Housing-Market sector.


Best Gold Stocks to Buy Now: AABB, GOLD, GDX
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Gold Prices Fall Amid Rate Jitters; Copper Steady as China Stimulus Eyed
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Thailand Inflation Remains Negative for 10th Straight Month in January
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



